Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-24-045153

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q3 2024 · Sep 30, 2024 $1.19M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $2.55M
Current Liabilities Q3 2024 · Sep 30, 2024 $9.34M
Current Liabilities Q3 2024 · Dec 31, 2023 $8.89M
Total Liabilities Q3 2024 · Sep 30, 2024 $9.38M
Total Liabilities Q3 2024 · Dec 31, 2023 $8.94M
Current Assets Q3 2024 · Sep 30, 2024 $1.24M
Current Assets Q3 2024 · Dec 31, 2023 $2.57M
Total Assets Q3 2024 · Sep 30, 2024 $2.03M
Total Assets Q3 2024 · Dec 31, 2023 $3.23M
Shares Diluted Q3 2024 · Sep 30, 2023 1.03B sh
Shares Diluted Q3 2024 · Sep 30, 2023 1.03B sh
Capex Q3 2024 · Sep 30, 2023 $6.4K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$916.76K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$5M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$4.51M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$3.52M
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Sga Expense Q3 2024 · Sep 30, 2023 $224.69K
Sga Expense Q3 2024 · Sep 30, 2023 $656.46K
Rd Expense Q3 2024 · Sep 30, 2023 $39.13K
Rd Expense Q3 2024 · Sep 30, 2023 $165.26K
Net Income Q3 2024 · Sep 30, 2023 −$549.27K
Net Income Q3 2024 · Sep 30, 2023 −$1.71M
Operating Income Q3 2024 · Sep 30, 2023 −$459.45K
Operating Income Q3 2024 · Sep 30, 2023 −$1.43M
Stock Issued Q3 2024 · Feb 16, 2023 2.43M sh